Mirko Griesel
YOU?
Author Swipe
View article: NCCN guideline–concordant cancer care in sub-Saharan Africa: a population-based multicountry study of 5 cancers
NCCN guideline–concordant cancer care in sub-Saharan Africa: a population-based multicountry study of 5 cancers Open
Background To assess population-based quality of cancer care in sub-Saharan Africa and to identify specific gaps and joint opportunities, we assessed concordance of diagnostics and treatments with National Comprehensive Cancer Network Harm…
View article: Systemic corticosteroids for the treatment of COVID-19
Systemic corticosteroids for the treatment of COVID-19 Open
View article: Treatment and Survival Among Patients With Colorectal Cancer in Sub-Saharan Africa: A Multicentric Population-Based Follow-Up Study
Treatment and Survival Among Patients With Colorectal Cancer in Sub-Saharan Africa: A Multicentric Population-Based Follow-Up Study Open
Background: The burden of colorectal cancer (CRC) is increasing in Sub-Saharan Africa (SSA). However, little is known about CRC treatment and survival in the region. Methods: A random sample of 653 patients with CRC diagnosed from 2011 to …
View article: Guideline Concordance of Treatment and Outcomes Among Adult Non-Hodgkin Lymphoma Patients in Sub-Saharan Africa: A Multinational, Population-Based Cohort
Guideline Concordance of Treatment and Outcomes Among Adult Non-Hodgkin Lymphoma Patients in Sub-Saharan Africa: A Multinational, Population-Based Cohort Open
Background Although non-Hodgkin lymphoma (NHL) is the 6th most common malignancy in Sub-Saharan Africa (SSA), little is known about its management and outcome. Herein, we examined treatment patterns and survival among NHL patients. Methods…
View article: Remdesivir for the treatment of COVID-19
Remdesivir for the treatment of COVID-19 Open
Based on the available evidence up to 31 May 2022, remdesivir probably has little or no effect on all-cause mortality or in-hospital mortality of individuals with moderate to severe COVID-19. The hospitalisation rate was reduced with remde…
View article: Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence
Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence Open
Systemic corticosteroids probably slightly reduce all-cause mortality up to 30 days in people hospitalised because of symptomatic COVID-19, while the evidence is very uncertain about the effect on all-cause mortality up to 120 days. For yo…
View article: Early spontaneous breathing for acute respiratory distress syndrome in individuals with COVID-19
Early spontaneous breathing for acute respiratory distress syndrome in individuals with COVID-19 Open
We found no direct evidence on whether early spontaneous breathing in SARS-CoV-2-induced ARDS is beneficial or detrimental to this particular group of patients. RCTs comparing early spontaneous breathing with ventilatory strategies not all…
View article: Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review-Update: Systemic corticosteroids for the treatment of COVID-19.
Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review-Update: Systemic corticosteroids for the treatment of COVID-19. Open
Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review-Update: Systemic corticosteroids for the treatment of COVID-19.
View article: Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review-Update: Systemic corticosteroids for the treatment of COVID-19.
Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review-Update: Systemic corticosteroids for the treatment of COVID-19. Open
Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review-Update: Systemic corticosteroids for the treatment of COVID-19.
View article: Awake Prone Positioning, High-Flow Nasal Oxygen and Non-Invasive Ventilation as Non-Invasive Respiratory Strategies in COVID-19 Acute Respiratory Failure: A Systematic Review and Meta-Analysis
Awake Prone Positioning, High-Flow Nasal Oxygen and Non-Invasive Ventilation as Non-Invasive Respiratory Strategies in COVID-19 Acute Respiratory Failure: A Systematic Review and Meta-Analysis Open
Background: Acute respiratory failure is the most important organ dysfunction of COVID-19 patients. While non-invasive ventilation (NIV) and high-flow nasal cannula (HFNC) oxygen are frequently used, efficacy and safety remain uncertain. B…
View article: Systemic corticosteroids for the treatment of COVID-19
Systemic corticosteroids for the treatment of COVID-19 Open
Moderate-certainty evidence shows that systemic corticosteroids probably slightly reduce all-cause mortality in people hospitalised because of symptomatic COVID-19. Low-certainty evidence suggests that there may also be a reduction in vent…
View article: Presentation, patterns of care, and outcomes of patients with prostate cancer in sub‐Saharan Africa: A population‐based registry study
Presentation, patterns of care, and outcomes of patients with prostate cancer in sub‐Saharan Africa: A population‐based registry study Open
Background Although prostate cancer (PCa) is the most commonly diagnosed cancer in men of sub‐Saharan Africa (SSA), little is known about its management and survival. The objective of the current study was to describe the presentation, pat…
View article: Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Remdesivir for the treatment of COVID-19
Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Remdesivir for the treatment of COVID-19 Open
Updated Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Remdesivir for the treatment of COVID-19.
View article: Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Remdesivir for the treatment of COVID-19
Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Remdesivir for the treatment of COVID-19 Open
Updated Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Remdesivir for the treatment of COVID-19.
View article: Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Systemic corticosteroids for the treatment of COVID-19.
Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Systemic corticosteroids for the treatment of COVID-19. Open
Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Systemic corticosteroids for the treatment of COVID-19.
View article: Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Systemic corticosteroids for the treatment of COVID-19.
Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Systemic corticosteroids for the treatment of COVID-19. Open
Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Systemic corticosteroids for the treatment of COVID-19.
View article: Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Systemic corticosteroids for the treatment of COVID-19.
Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Systemic corticosteroids for the treatment of COVID-19. Open
Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Systemic corticosteroids for the treatment of COVID-19.
View article: Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Systemic corticosteroids for the treatment of COVID-19.
Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Systemic corticosteroids for the treatment of COVID-19. Open
Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Systemic corticosteroids for the treatment of COVID-19.
View article: Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Systemic corticosteroids for the treatment of COVID-19.
Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Systemic corticosteroids for the treatment of COVID-19. Open
Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Systemic corticosteroids for the treatment of COVID-19.
View article: Cervical Cancer in Sub-Saharan Africa: A Multinational Population-Based Cohort Study of Care and Guideline Adherence
Cervical Cancer in Sub-Saharan Africa: A Multinational Population-Based Cohort Study of Care and Guideline Adherence Open
Background Cervical cancer (CC) is the most common female cancer in many countries of sub-Saharan Africa (SSA). We assessed treatment guideline adherence and its association with overall survival (OS). Methods Our observational study cover…
View article: Clinical presentation and diagnosis of adult patients with non‐Hodgkin lymphoma in Sub‐Saharan Africa
Clinical presentation and diagnosis of adult patients with non‐Hodgkin lymphoma in Sub‐Saharan Africa Open
Summary Non‐Hodgkin lymphoma (NHL) is the sixth most common cancer in Sub‐Saharan Africa (SSA). Comprehensive diagnostics of NHL are essential for effective treatment. Our objective was to assess the frequency of NHL subtypes, disease stag…
View article: Addis Ababa population-based pattern of cancer therapy, Ethiopia
Addis Ababa population-based pattern of cancer therapy, Ethiopia Open
Cancer in Sub-Saharan Africa is becoming an important challenge for health services due to rising numbers of patients. In Addis Ababa with around 3.5 million inhabitants, more than 2000 cases are diagnosed annually. In this retrospective p…
View article: Breast Cancer Treatment in Sub-Saharan Africa: A Population-Based Registry Study
Breast Cancer Treatment in Sub-Saharan Africa: A Population-Based Registry Study Open
Purpose Stage at diagnosis and receipt of therapy are the most important determinants of breast cancer (BC) survival in sub-Saharan Africa (SSA). Recently, the National Comprehensive Cancer Network therapy guidelines for SSA were published…